Search

everythinglearnresearchcommunity

for

Search:↓

Insulin resistance might not be enough to worsen blood vessel function in young, nonobese women with polycystic ovary syndrome.

Hair regrowth was seen in 83% of children with alopecia, immune system plays a role in the condition, and various treatments showed effectiveness for hair and nail disorders.

Lipocalin-2 levels are higher in women with PCOS and may indicate insulin resistance.

Photobiomodulation therapy using red and near-infrared light can reduce inflammation and aid in healing various conditions.

Women with PCOS who have low SHBG are more likely to have low good cholesterol and metabolic syndrome.

Metformin helps manage diabetes, PCOS, and weight in kids but needs more research for long-term safety.

PCOS is a common condition in women that can lead to infertility and other health issues, and it's diagnosed by specific criteria with various treatment options available.

Hirsutism is mainly caused by high androgen levels or sensitivity, with PCOS being the most common cause.

Children with classic congenital adrenal hyperplasia have thicker heart fat and are at higher risk for heart problems and early atherosclerosis.

Certain drugs and supplements may contribute to hair loss in the frontal hairline in older women.

High glucocorticoids cause pancreatic malfunction and malabsorption, reversible with enzyme supplements.

The document concludes that managing PCOS involves treating symptoms and reducing long-term metabolic risks, with lifestyle changes being important.

Some women with PCOS have rare genetic variants linked to the condition.

ADAM17 could be a potential target for treating PCOS.

New treatments are needed for PCOS that target its genetic, hormonal, and metabolic causes.

5-alpha reductase inhibitors may cause sexual side effects, breast complications, and other health risks in men with hair loss.

Nourkrin® with Marilex® may significantly increase hair growth and alopecia could be an early sign of metabolic syndrome.

The 2003 consensus updated PCOS diagnosis criteria and linked PCOS to higher risks of diabetes and heart problems, recommending lifestyle changes to lower these risks.

Hormonal imbalances in Polycystic Ovarian Syndrome (PCOS) might trigger a rare skin disorder called Confluent and Reticulated Papillomatosis (CRP), so dermatologists should consider checking for PCOS in CRP patients.

Troglitazone increases subcutaneous fat in lipodystrophy patients.

Mice lacking the PPARγ gene in their fat cells had almost no fat tissue, severe metabolic problems, and abnormal development of other fat-related tissues.

Eating healthy, exercising, and taking certain supplements can help manage Polycystic Ovary Syndrome symptoms.

The trial aims to test if spironolactone is an effective acne treatment for women without the side effects of current treatments.

Diagnosing and treating PCOS in teenagers is difficult, and the focus is on lifestyle changes and medication to improve health and prevent future issues.

LEF1 is essential for the development of airway glands and is regulated by the Wnt/ß-catenin pathway.

New treatments for PCOS focus on managing symptoms and improving fertility.

Enobosarm significantly increased muscle mass and improved physical function in elderly men and postmenopausal women without serious side effects.

Diagnosing and managing Glucocorticoid Resistance Syndrome is complex due to genetic differences and varied symptoms.

Skin diseases linked to insulin resistance should be managed to prevent diabetes and reduce heart disease risk.

Lipocalin-Type Prostaglandin D2 Synthase (L-PGDS) is a protein that plays many roles in the body, including sleep regulation, pain management, food intake, and protection against harmful substances. It also affects fat metabolism, glucose intolerance, cell maturation, and is involved in various diseases like diabetes, cancer, and arthritis. It can influence sex organ development and embryonic cell differentiation, and its levels can be used as a diagnostic marker for certain conditions.